SCHEMBL27612968

SCHEMBL27612968

Fc1cncnc1.Nc1nc(N)c(F)c(-c2cccc(O)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 9/20 0.50
▸ PIK3CA P42336 4/20 0.50
▸ PIK3CB P42338 4/20 0.50
▸ PIK3CD O00329 3/20 0.50
▸ ABL1 P00519 2/20 0.50
▸ EGFR P00533 2/20 0.50
▸ MTOR P42345 2/20 0.50
▸ PI4KB Q9UBF8 2/20 0.50
▸ PIK3C2B O00750 1/20 0.50
▸ PDXK O00764 1/20 0.50
▸ GAK O14976 1/20 0.50
▸ MAP3K7 O43318 1/20 0.50
▸ RIPK2 O43353 1/20 0.50
▸ PIP5K1C O60331 1/20 0.50
▸ STK16 O75716 1/20 0.50
▸ PIK3C2G O75747 1/20 0.50
▸ PRKD3 O94806 1/20 0.50
▸ OXSR1 O95747 1/20 0.50
▸ LATS1 O95835 1/20 0.50
▸ ERBB2 P04626 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116418 0.89 PIK3CG (0.60) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL27631865 0.79 ADORA2A (0.51) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL27631647 0.77 PIK3CG (0.45) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL27612727 0.76 ADORA2A (0.54) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL27631687 0.74 ADORA2A (0.45) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL27612794 0.73 PIK3CG (0.61) PIK3CGPIK3CAPIK3CBPIK3CDABL1
Hydrochloric Acid SCHEMBL27631852 0.73 ADORA2A (0.44) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL19932545 0.72 ADORA2A (0.43) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL4419371 0.72 HRH2 (0.47) PIK3CGPIK3CAPIK3CBPIK3CDABL1
SCHEMBL4411196 0.72 RAB9A (0.56) PIK3CGADORA1ADORA2AADORA2BSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 — — CN disclosed
Send feedback